Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 4,364 | 3,523 | 0 | 34,424 | 2,968 |
| Cost of Goods | 730 | 630 | 0 | 8,144 | 1,525 |
| Gross Profit | 3,634 | 2,893 | 0 | 26,280 | 1,443 |
| Operating Expenses | 28,034 | 32,082 | 34,063 | 38,596 | 38,499 |
| Operating Income | -23,670 | -28,559 | -34,063 | -12,172 | -36,531 |
| Other Income | -3,612 | -4,739 | -674 | 554 | 2 |
| Pre-tax Income | -27,282 | -33,298 | -34,737 | -11,618 | -36,529 |
| Net Income Continuous | -27,282 | -33,298 | -34,737 | -11,618 | -36,529 |
| Net Income Discontinuous | 85,319 | 3,355 | 6,947 | N/A | N/A |
| Net Income | $58,037 | $-29,943 | $-27,790 | $-11,618 | $-36,529 |
| EPS Basic Total Ops | 6.10 | -3.20 | -3.00 | -1.30 | -4.30 |
| EPS Basic Continuous Ops | -2.90 | -3.60 | -3.80 | -1.28 | -4.32 |
| EPS Basic Discontinuous Ops | 9.00 | 0.40 | 0.80 | N/A | N/A |
| EPS Diluted Total Ops | 6.10 | -3.20 | -3.00 | -1.30 | -4.30 |
| EPS Diluted Continuous Ops | -2.90 | -3.60 | -3.80 | -1.28 | -4.32 |
| EPS Diluted Discontinuous Ops | 9.00 | 0.40 | 0.80 | N/A | N/A |
| EBITDA(a) | $-20,855 | $-24,975 | $-30,524 | $-8,480 | $-32,900 |